logo-loader
AIM:ETX OTCQX:ETXPF

e-Therapeutics PLC

Receive alerts
Market:
AIM
Price
11.49 GBX
Day Change
3.09%
Market Cap:
£67.16 m
52 weeks high
24.00
52 weeks low
8.00

In brief

e-Therapeutics PLC is integrating computational power and biology to accelerate the discovery of life-transforming RNAi medicines.

The company has developed and validated a powerful computational approach to drug discovery, leveraging our industry-leading expertise in network biology to fully capture and interrogate human disease complexity.

e-Therapeutics' multi-disciplinary team builds computational models of biological functions to transform the search for new medicines, interventions, mechanisms and genetic support.

Snapshot

  • e-therapeutics 'actively exploring' potential partnerships as AI approach yields results
  • e-Therapeutics using Open AI technology in drug discovery
  • e-Therapeutics working to capitalise on AI "blindside"

Insight Widest with the analysis, Proactive gives perspectives that others don't.